Through in vitro and in vivo assays, we observed that MSI2 can enhance immune infiltration and the inflammatory response in CRC, with effects such as increasing the proportions of DCs, CD4+ T cells and CD8+ T cells and the production and secretion of inflammatory factors, cytokines and chemokines. This evidence concerns the gene CD4 and colorectal carcinoma.